How was San Francisco?
We're still knee-deep in our follow up activities from the San Francisco conferences and receptions. Specifically, we spent the bulk of our time at the rapidly-growing Biotech Showcase…
Menu
BIO Europe 2013 – Tying It All Together
We've returned from another successful BIO Europe conference, this time in Vienna. We regret not having much time to walk around in Vienna. However, this did not take away…
BIO Europe Preparation Video
Lacerta Bio is pleased to announce our participation in the 19th Annual BIO-Europe Conference in Vienna, Austria. As with last year's conference in Hamburg, this year's…
BIO2013: The Afterglow Edition
As we were making our way back home from Chicago (on delayed flights, of course), several things struck us about BIO2013. We've talked about BIO in the past.…
ExcipientFest 2013
Now that we're back from BIO2013, we have to leave again! We'll be at ExcipientFest 2013 in Baltimore for a few days. We'll be meeting with several Exhibitors,…
Getting the Most out of BIO
Rob Wright has a really good article on preparing for BIO. In fact, it's applicable for just about any major conference or convention. You can read the entire…
Tips for Attending Conferences
As BD consultants, we attend a number of conferences, both large and small. Some have one-on-one meetings, some don't. Some are scientific conferences, while others are focused on partnering. As…
Observations from JPM 2013
Lacerta Bio, along with approximately 10,000 other life science investors, executives, consultants, service providers, hangers-on, and many others, congregated in San Francisco for a variety of conferences, including the JP…
Stories of Interest in 2012
As we bring 2012 to a close, we're looking back at a few of the interesting events that took place. It was a challenge to whittle this down to a…
Radio Silence: Three Reasons Why It Happens in BD
Consider the following situation: You are out-licensing an innovative asset in a niche therapeutic area It is a first-in-class molecule It has successfully demonstrated efficacy in two international Phase…